You will be embedded in two research groups, that of Prof. dr. Rob Collin (Department of Human Genetics) and that of Prof. dr. Roland Brock (Department of Medical Biosciences).
This PhD project is integrated in and financed by a large national consortium, Lifelong VISION, a Gravitation project funded by the Dutch Ministry of Education, Culture and Science (2024- 2033), that aims to develop new treatments against blindness. The Lifelong VISION program is developing a new generation of treatment strategies to prevent blindness: genetic therapies, treatments that target the disease pathways, and cell therapies. State of the art cell and animal models will be developed to test these new therapies in vitro and in vivo. The suitability of each patient group, and the optimal timing for therapeutic intervention is predicted using artificial intelligence, so that the right patient receives the right treatment at the right time. The innovative technologies and strategies developed for eye diseases within our project may serve as blueprints for other diseases and organs.
Ten research institutions participate in the Lifelong Vision project (led by prof. dr. Caroline Klaver), namely: Radboudumc, Erasmus MC, Amsterdam UMC, University of Twente, Hubrecht Institute, Eindhoven University of Technology, University of Amsterdam, Utrecht University, Tilburg University, and the Netherlands Institute for Neuroscience.
As a result, you will be exposed to a broad multidisciplinary environment, both intramurally and (inter)nationally.
